Abstract
Cancer stem cells (CSCs) are cancer cells with characteristics of stem cells, especially the ability to arise to all types of cell in a particular cancer tissue. With the capacity to generate multiple types of cancer cells, CSCs are proposed as primary impetus for tumor initiation and metastases and are suggested as potential therapeutic targets for anti-cancer treatment. Peroxisome-proliferatoractivated receptors (PPARs) are a subset of multifunctional transcription factors which play a pivotal role in cancer development and tumorigenesis. PPARs are also reported to be involved in the modulation of the epithelial-mesenchymal transition (EMT) process in CSC initiation and in the regulation of CSC functions. However, the exact mechanisms remain unknown. Herein, we review the latest evidence on the regulatory effects and mechanisms of PPARs in CSC formation and function, and evaluate the prospects of PPARs as a target for cancer treatment.
Keywords: Cancer, cancer stem cells, EGF/bFGF signaling pathway, epithelial-mesenchymal transition, peroxisomeproliferator- activated receptors, Sonic hedgehog signaling pathway.
Current Stem Cell Research & Therapy
Title:Expression and Function of PPARs in Cancer Stem Cells
Volume: 11 Issue: 3
Author(s): Yiming Zhang, Xu Zhang, Jing Wang, Yun Shen, Xiaoshan Tang, Fang Yu and Raorao Wang
Affiliation:
Keywords: Cancer, cancer stem cells, EGF/bFGF signaling pathway, epithelial-mesenchymal transition, peroxisomeproliferator- activated receptors, Sonic hedgehog signaling pathway.
Abstract: Cancer stem cells (CSCs) are cancer cells with characteristics of stem cells, especially the ability to arise to all types of cell in a particular cancer tissue. With the capacity to generate multiple types of cancer cells, CSCs are proposed as primary impetus for tumor initiation and metastases and are suggested as potential therapeutic targets for anti-cancer treatment. Peroxisome-proliferatoractivated receptors (PPARs) are a subset of multifunctional transcription factors which play a pivotal role in cancer development and tumorigenesis. PPARs are also reported to be involved in the modulation of the epithelial-mesenchymal transition (EMT) process in CSC initiation and in the regulation of CSC functions. However, the exact mechanisms remain unknown. Herein, we review the latest evidence on the regulatory effects and mechanisms of PPARs in CSC formation and function, and evaluate the prospects of PPARs as a target for cancer treatment.
Export Options
About this article
Cite this article as:
Zhang Yiming, Zhang Xu, Wang Jing, Shen Yun, Tang Xiaoshan, Yu Fang and Wang Raorao, Expression and Function of PPARs in Cancer Stem Cells, Current Stem Cell Research & Therapy 2016; 11 (3) . https://dx.doi.org/10.2174/1574888X10666150728122921
DOI https://dx.doi.org/10.2174/1574888X10666150728122921 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours
Current Signal Transduction Therapy A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential
Current Drug Targets Integrins Modulate Cellular Fibrogenesis at Multiple Levels: Regulation of TGF-β Signaling
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine Assessing Drug Transport Across the Human Placental Barrier: From In Vivo and In Vitro Measurements to the Ex Vivo Perfusion Method and In silico Techniques
Current Pharmaceutical Biotechnology Safety of Technosphere Inhaled Insulin
Current Drug Safety In vitro Propagation of Cichorium intybus L. and Quantification of Enhanced Secondary Metabolite (Esculin)
Recent Patents on Biotechnology Medulloblastoma: Role of Developmental Pathways, DNA Repair Signaling, and Other Players
Current Molecular Medicine DNAzyme Delivery Approaches in Biological Settings
Current Medicinal Chemistry Emerging Endocrine Therapies in the Treatment of HR-Positive Metastatic Breast Cancer
Current Cancer Therapy Reviews Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer
Current Topics in Medicinal Chemistry Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment
Current Pharmaceutical Biotechnology Erythropoietin in Cancer: An Update
Current Molecular Medicine Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?
Recent Patents on Anti-Cancer Drug Discovery Regulation of ABC Transporter Function Via Phosphorylation by Protein Kinases
Current Pharmaceutical Biotechnology Graphene Oxide: A Carrier for Pharmaceuticals and a Scaffold for Cell Interactions
Current Topics in Medicinal Chemistry The Role of Chronic Periodontitis in Prevention and Treatment of Head and Neck Cancers
Current Cancer Therapy Reviews The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer
Current Cancer Drug Targets The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
Current Pharmaceutical Biotechnology